Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of GDC-0917 in patients with refractory solid tumors or lymphoma has completed. The study assessed safety, tolerability, and p…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating acupuncture to treat chemotherapy-induced peripheral neuropathy in patients with lymphoma or multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial investigating pre-reinductive decitabine and vorinostat in relapsed lymphoblastic lymphoma or acute lymphoblastic l…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Fungemia in Hematologic Malignancies
This clinical trial update notes the completion of a study on fungemia (fungal bloodstream infections) in patients with hematologic malignan…
-
CLINICAL_TRIALS research · 2016-10-17Clinical Trial Update: Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
An update on a clinical trial evaluating whole-body PET-MRI for pediatric and adolescent lymphoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-10-12Clinical Trial Update: Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors [Phase 4]
This entry notes a Phase 4 clinical trial comparing standard versus individualized treatment for relapse and refractory lymphoma, with the t…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective
This clinical trial update reports on the time and effort required to collect peripheral blood stem cells in lymphoma patients from a Europe…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety and Pharmacokinetic Profile of CKD-581 [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetic profile of CKD-581 in patients with lymphoma and multiple myeloma. The study has…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy [Phase 1]
A Phase 1 trial evaluating a monoclonal antibody therapy in patients with lymphoma or colon cancer unresponsive to vaccine therapy; the stud…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan and fludarabine followed by post-transplant cyclophosphamide in patients with he…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF for neutropenia after chemotherapy in patients with breast c…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical trial update on PEG-rhG-CSF for lymphoma patients after autologous hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations [NA]
Completed clinical trial aimed at creating a normal database for FDG-PET neurological examinations, sponsored by Central Hospital, Nancy, Fr…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors [Phase 2]
Phase 2 trial evaluates glutamine for vincristine-induced neuropathy in pediatric patients with lymphoma, leukemia, or solid tumors. The stu…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
This study analyzes data from the EBMT registry on patients receiving plerixafor, summarizing outcomes in lymphoma and multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan [Phase 2]
Phase 2 trial evaluating safety and efficacy of Nipent, Cytoxan, and Rituxan in lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)
The CARDIOTOX trial evaluating early assessment of anthracycline-induced cardiotoxicity has been terminated.
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Institut Paoli Calmettes Lymphoma Database
Clinical trial update indicates recruitment is ongoing for a lymphoma study sponsored by Institut Paoli-Calmettes.
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy and rituximab with or without total-body irradiation and peripheral stem cell transplant in lymphoma; …
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies [Phase 1]
This Phase 1 clinical trial update reports on an anti-CD19 CAR-T cell therapy being tested in patients with B cell malignancies, including c…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Signal Detection in Monoclonal and New Agents in Lymphoma
The clinical trial NCT02849912 examining signal detection related to monoclonal antibodies and new agents in lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Phase II Study of Umbilical Cord Blood Transplantation [Phase 2]
A Phase II study of Umbilical Cord Blood Transplantation was terminated, with results posted in 2016 for diseases including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma [Phase 2]
This Phase 2 trial evaluates conditioning with fludarabine and cyclophosphamide followed by peripheral stem cell transplant in patients with…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating epoetin alfa for chemotherapy-induced anemia has completed, with an update summarizing trial status across multip…